Clinical Trials on Primary Immune Deficiency (PID) in Canada

Total 669 results

Baxalta now part of Shire
Baxalta Innovations GmbH, now part of Shire

Completed

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Primary Immunodeficiency Diseases (PID)

Canada
Therapure Biopharma Inc

Unknown

Study of PlasmaCap IG in Adults and Children With PIDD

Primary Immune Deficiency Diseases (PIDD)

United States, Canada
Baxalta now part of Shire

Completed

Gammagard Liquid and rHuPH20 in PID

Primary Immunodeficiency Diseases (PID)

United States, Canada
Baxalta now part of Shire

Completed

Phase 2/3 Study of IGSC, 20% in PIDD

Primary Immunodeficiency Diseases (PID)

United States, Canada
CSL Behring

Completed

Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules

Primary Immune Deficiency | Secondary Immune Deficiency

Canada
University of Alberta
Octapharma

Recruiting

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

Primary Immune Deficiency Disorder | Secondary Immune Deficiency

Canada
Octapharma

Completed

Octagam 5% Versus Comparator Post Marketing Trial

Primary Immune Deficiency Disorder

United States
Octapharma

Completed

Study of Octanorm Subcutaneous IG in Patients With PID

Primary Immune Deficiency Disorder

United States, Canada, Czechia, Hungary, Poland, Russian Federation, Slovakia
Lawson Health Research Institute

Completed

Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies

HIV Infections | Cancer, Second Primary

Canada
Grifols Therapeutics LLC

Completed

A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency

Immunologic Deficiency Syndrome

United States, Canada
Ottawa Hospital Research Institute
Octapharma

Unknown

Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment

Primary Immunodeficiency Disease | Secondary Immunodeficiency

Canada
Green Cross Corporation
Atlantic Research Group

Completed

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Immunologic Deficiency Syndrome

United States, Canada
Qu Biologics Inc.
The National Research Council of Canada Industrial Research Assistance Program

Active, not recruiting

Assessment of QBKPN Site-Specific Immunomodulator Efficacy in Improving Innate Immune Function & Reducing Respiratory Tract Infection Morbidity in Older Adults (RESILIENCE)

Immune Deficiency

Canada
Octapharma

Completed

CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL

Primary Immunodeficiency

United States, Canada
University of North Carolina, Chapel Hill
The Hospital for Sick Children; Washington University School of Medicine; McGill... and other collaborators

Recruiting

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

Primary Ciliary Dyskinesia | Kartagener Syndrome | Primary Immune Deficiency

United States, Canada
CSL Behring

Completed

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Primary Immunodeficiency

United States, Canada
AbbVie

Recruiting

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Human Immuno-deficiency Virus (HIV) Disease

United States, Puerto Rico, Japan, Spain, Germany, Canada, Belgium, France
Gilead Sciences

Recruiting

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

HIV Infections | Acquired Immune Deficiency Syndrome (AIDS)

United States, South Africa, Argentina, Panama, Thailand, Zimbabwe, United Kingdom, Uganda
University of North Carolina, Chapel Hill
The Hospital for Sick Children; Washington University School of Medicine; McGill... and other collaborators

Recruiting

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Primary Ciliary Dyskinesia | Kartagener Syndrome | Primary Immune Deficiency

United States, Canada
Kedrion S.p.A.

Completed

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

Primary Immunodeficiency | Hypogammaglobulinemia | Agammaglobulinemia | Antibody Deficiency

United States, Canada
Hamilton Health Sciences Corporation
London Health Sciences Centre

Completed

Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant

Renal Insufficiency, Chronic | Zinc Deficiency | Trace Element Excess | Trace Element Deficiency

Canada
St. Justine's Hospital
Toronto-Dominion Bank of Canada Funds for Clinical Research projects.

Completed

Pilot Study of a New Device (Buzzy®) for Procedural Pain Relief During Needle-Related Procedures in Paediatric Patients

Immune Deficiency | Autoimmune Rheumatologic Disease | Pain Due to Certain Specified Procedures | Child/Adolescent Problems

Canada
Grifols Therapeutics LLC

Completed

Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency

Primary Immunodeficiency

United States, Canada
Acasti Pharma Inc.

Active, not recruiting

Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects

Ataxia Telangiectasia

Canada
McGill University Health Centre/Research Institute...
ViiV Healthcare; CIHR Canadian HIV Trials Network

Completed

Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations (TRIIADD)

HIV Infections

Canada
GAAD Medical Research Institute Inc.

Unknown

Energy Specific Far Infrared Radiation Treatment for AIDS

HIV Infections

Canada
Unity Health Toronto
Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network

Recruiting

Optimizing the Delivery of HIV nPEP

HIV Infections

Canada
McGill University Health Centre/Research Institute...

Completed

Camu Camu in ART-treated People Living With HIV

HIV Infections

Canada
Ottawa Hospital Research Institute
Ontario HIV Treatment Network

Completed

Supportive Therapy for Adherence to ART(STAART)

HIV Infections

Canada
McGill University Health Centre/Research Institute...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal; CIHR... and other collaborators

Terminated

Cannabinoids in PLWHIV on Effective ART

HIV Infections

Canada
McGill University Health Centre/Research Institute...
CIHR Canadian HIV Trials Network

Unknown

Electronic Capture of Adherence Barriers for HIV Care (CTNPT039)

HIV Infections

Canada
McGill University Health Centre/Research Institute...
Merck Sharp & Dohme LLC

Withdrawn

Immune Responses in Patients Treated With Raltegravir (RAG-1/2)

HIV Infections

Canada
Ottawa Hospital Research Institute
DNA Genotek (has supplied the kits)

Completed

Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit

HIV Infections

Canada
Mount Sinai Hospital, Canada
Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Canadian Foundation...

Completed

A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV

HIV Infections

Canada
Ottawa Hospital Research Institute
Bristol-Myers Squibb

Completed

Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study

HIV Infection

Canada
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (RICHI)

Chronic Granulomatous Disease | Hemophagocytic Lymphohistiocytosis | Leukocyte Adhesion Deficiency | Chronic Active Epstein-Barr Virus Infection | HIGM-1 | IPEX

United States, Canada
University Health Network, Toronto
CSL Behring

Completed

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients (ScIGalloHCT)

Hypogammaglobulinemia

Canada
McGill University Health Centre/Research Institute...

Not yet recruiting

The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study

HIV Infections

Canada
University of British Columbia

Completed

Switch to Unboosted Atazanavir With Tenofovir Study (SUAT)

HIV Infection

Canada
University of British Columbia

Terminated

Pilot Study of Diflunisal in HIV-infected Adults

HIV Infection

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Combination Vaccination Before HIV Treatment Interruption

HIV Infections

Canada
University of British Columbia
National Institute on Drug Abuse (NIDA)

Completed

Use of Incentives to Retain Drug Users in HIV Therapy (Incentives-2)

HIV Infection

Canada
University of British Columbia
Gilead Sciences

Completed

Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy (QuaDar)

HIV Infection

Canada
University of British Columbia
National Institute on Drug Abuse (NIDA)

Completed

Use of Incentives to Engage Drug Users in HIV Therapy (Incentives-1)

HIV Infection

Canada
Ottawa Hospital Research Institute

Completed

Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure

Anemia | Renal Failure

Canada
CSL Behring

Completed

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

Common Variable Immunodeficiency | Agammaglobulinemia

Canada, Germany, Italy, Spain
Melissa Brooks
University of British Columbia; Nova Scotia Health Authority; Dalhousie University and other collaborators

Recruiting

A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial

Abortion in First Trimester | Abortion Early | Decision Aid | Clinical Decision-making | Abortion, Therapeutic

Canada
Georges Ouellet

Completed

Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients

Inflammation | Oxidative Stress | Iron-Deficiency Anemia

Canada
Dr. Bertrand Lebouche

Recruiting

Antiretroviral Speed Access Program (ASAP)

HIV Infection

Canada
Theratechnologies

Completed

Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients

HIV

Canada

Clinical Trials on Primary Immune Deficiency (PID) in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations